Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Yliver as a Test to Early Diagnose Hepatocellular Carcinoma

NCT03767764 is registered in ClinicalTrials.gov with Corporacion Parc Tauli as lead sponsor.

NCT NCT03767764
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03767764 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Yliver as a Test to Early Diagnose Hepatocellular Carcinoma
Lead sponsor
Corporacion Parc Tauli
Phase
Observational
Overall status
Completed
Start date
December 27, 2018
Completion date
September 1, 2020
Enrollment
190 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma